AAPG
Ascentage Pharma Group International
16.30$
+0.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.2% | 71.3% | 80.5% | 75.4% | 62.3% | 64.1% | 57.8% | 53.8% | 56.3% | 74.3% | |
| 49.6% | 2.5% | 77.9% | 72.9% | 58.9% | 58.1% | 52.1% | 42.8% | 47.2% | 62.3% | |
| 76.2% | 68.6% | 79.0% | 72.9% | 58.9% | 58.1% | 52.1% | 42.8% | 47.2% | 62.3% | |
| 1.4% | 1.4% | 0.4% | 0.2% | 0.0% | 1.8% | 2.2% | 6.5% | 3.8% | 6.4% | |
| – | – | – | – | 0.0% | 0.1% | 0.3% | 0.6% | 0.3% | 0.7% | |
| 4.2% | 4.2% | 2.0% | 2.0% | 1.4% | 0.8% | 0.9% | 1.0% | 0.9% | 0.6% | |
| 14.7% | 13.9% | 8.8% | 8.7% | 5.6% | 2.1% | 3.0% | 3.4% | 2.9% | 1.7% | |
| 102.5% | 122.7% | 182.3% | 26.1% | 51.1% | 58.0% | 85.6% | 97.2% | 89.5% | 66.3% | |
| 13.1% | 13.7% | 8.6% | 16.8% | 16.0% | 12.3% | 31.1% | 37.4% | 44.6% | 41.5% | |
| 0.1% | 0.3% | 3.1% | 7.7% | 2.9% | 1.7% | 18.3% | 24.7% | 29.8% | 30.8% | |
| 0.0% | 0.7% | 0.4% | 1.1% | 1.3% | 2.4% | 3.4% | 2.9% | 3.5% | 2.7% | |
| – | – | – | – | 27.3% | 34.9% | 44.7% | 46.6% | 33.2% | 18.7% | |
| -2.5% | -22.7% | -82.3% | 73.9% | 48.9% | 42.0% | 14.4% | 2.4% | 10.1% | 33.4% | |
| -25.6% | -46.5% | -50.1% | -174.0% | -160.3% | -121.0% | -156.9% | -214.6% | -220.4% | -176.8% | |
| 2.2% | 2.2% | 1.1% | 1.1% | 0.8% | 0.5% | 0.6% | 0.7% | 2.9% | 2.2% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.